TD Cowen acted as sole book running manager for the offering.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JSPR:
- Jasper Therapeutics announces common stock offering, no amount given
- Jasper Therapeutics price target lowered to $25 from $29 at UBS
- Hold Rating on Jasper Therapeutics Amid Uncertainty in BEACON Study and Drug Development Timeline
- Jasper Therapeutics Faces Business Risks Amid Clinical Trial Delays and Competitive Pressures
- Jasper Therapeutics: Promising Clinical Data and Strategic Focus Drive Buy Rating